A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

Biosimilars have been available in Europe for years. Is the US still lagging behind?

What happened in May in the biopharma industry? Here’s our roundup of the biggest headlines.

How can pharma help save the environment? We need to use green chemistry, reduce cleanroom sizes, and use less energy.

A question of sustainability: how can pharma companies up their environmental Game? Experts discuss in our video roundtable.

Moderna’s new CFO lasts one day in the job as investigation comes to light.

What will drug development look like aboard a new commercial space station?

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

How an initiative from EFPIA and a new public database on chemical substances could reduce animal experiments.